Platform-technology deals increasingly will drive genomics and gene therapy alliances

被引：0
|
作者：
Lytton, M [1 ]
机构：
[1] PALMER & DODGE LLP,TECHNOL GRP,BOSTON,MA
来源：
GENETIC ENGINEERING NEWS | 1997年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：4 / &
相关论文
共 10 条
  • [1] Hepatic Delivery of Genes Encoding Therapeutic Proteins or Mirnas Using Hyperactive Transposons: A Platform Technology for Gene Therapy and Functional Genomics In Vivo
    Di Matteo, Mario
    De Bleser, Pieter
    Samara-Kuko, Ermira
    Chuah, Marinee
    VandenDriessche, Thierry
    MOLECULAR THERAPY, 2013, 21 : S136 - S137
  • [2] A novel genomics-based platform for the creation of synthetic promoters for cell and gene therapy
    Iglesias, J. M.
    Fraser, R. M.
    Moran, S.
    del Rio, P.
    Baker, K.
    Cooper, S.
    Whyteside, G.
    Braae, A.
    Kippen, N.
    Katsoupi, P.
    Torrance, V.
    Rajan, R.
    Yanez, J. O.
    Roberts, M. L.
    HUMAN GENE THERAPY, 2018, 29 (12) : A166 - A166
  • [3] Targeted Nano-Particles (TNP) Technology as a Universal and Versatile Platform for Gene Therapy
    Pacherie, Rachel
    Leclere, Laurence
    Lhuaire, Marion
    Maunichy, Eva
    Duchene, Charles
    Girardon, Maxime
    Tezgel, Ozgul
    Mourlane, Frederic
    Vaillant, Renaud
    Bauche, Cecile
    MOLECULAR THERAPY, 2021, 29 (04) : 223 - 223
  • [4] Targeted Nano-particles (TNP) technology as a universal and versatile platform for gene therapy.
    Pacherie, R.
    Leclere, L.
    Lhuaire, M.
    Maunichy, E.
    Duchene, C.
    Girardon, M.
    Mourlane, F.
    Vaillant, R.
    Bauche, C.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A95 - A95
  • [5] Using a novel cellular platform to optimize CRISPR/CAS9 technology for the gene therapy of AIDS
    Jingjin He
    Thanutra Zhang
    Xuemei Fu
    Protein & Cell, 2017, 8 (11) : 848 - 855
  • [6] Using a novel cellular platform to optimize CRISPR/CAS9 technology for the gene therapy of AIDS
    He, Jingjin
    Zhang, Thanutra
    Fu, Xuemei
    PROTEIN & CELL, 2017, 8 (11) : 848 - 852
  • [7] A new platform technology for next generation lysosomal enzyme replacement and potential gene therapy in the treatment of lysosomal diseases
    Liu, Lin
    Zhong, Ling
    Cuong Do
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S99 - S99
  • [8] Universal Stem Cell Gene Therapy Platform: Broadening the Transient Epigenetic Gene Therapy Arm by Using Nuclease-Null dCas9 as an Additional Drive for Efficient Epigenetic Editing
    Bertolotti, Roger
    MOLECULAR THERAPY, 2015, 23 : S101 - S102
  • [9] DEVELOPMENT OF THE PIN-POINITM PLATFORM: A VERSATILE BASE EDITING TECHNOLOGY WITH BROAD CAS ENZYME AND DEAMINASE COMPATIBILITY FOR CELL AND GENE THERAPY
    Blassberg, R.
    Russell, P.
    Joubert, B.
    Mielczarek, O.
    Gurule, N.
    Smeester, B.
    Hinsdale, S.
    Prestil, R.
    Kaufman, A. L.
    Stombaugh, J.
    Porreca, I.
    Hemphill, K.
    Perez-Duran, P.
    CYTOTHERAPY, 2024, 26 (06) : E28 - E29
  • [10] Integration of a modularized protein engineering technology and the RheoSwitch Therapeutic System® platform to develop high affinity trastuzumab single chain variable fragment-Fc proteins for gene therapy applications
    Reed, Charles
    Dailey, Vernon
    Elayadi, Anissa
    Williams, Lindsay
    Schneider, Dina
    Reed, Thomas
    Lewis, Jonathan
    Einstein, Richard
    Broder, Samuel
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
1